SCOPUS 정보 검색 플랫폼

Volumn 13, Issue 2, 2000, Pages 142-145

Efficacy of Daclizumab in an African-American and Hispanic renal transplant population

(6) Meier Kriesche, Herwig Ulf a Palenkar, Sadanand S b Friedman, Gary S c Mulgaonkar, Shamkant P c Goldblat, Melvin V c Kaplan, Bruce c,d

a UNIVERSITY OF TEXAS (United States)

b NEWARK BETH ISRAEL MEDICAL CENTER (United States)

c SAINT BARNABAS MEDICAL CENTER (United States)

d UNIVERSITY OF MICHIGAN (United States)

Author keywords

Daclizumab; High risk population; Immunosuppression; Kidney transplantation

Indexed keywords

CALCINEURIN; ESTERASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CALCINEURIN; COHORT STUDIES; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; UNITED STATES;

EID: 0034047643 PISSN: 09340874 EISSN: None Source Type: Journal
DOI: 10.1007/s001470050675 Document Type: Article

Times cited : (9)

References (8)

1
- 0029958452
- Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences
- Bleyer AJ, Tell GS, Evans GW, Ettinger WHJ, Burkart JM (1996) Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences. Am J Kidney Dis 28: 72-81
- (1996) Am J Kidney Dis , vol.28 , pp. 72-81
- Bleyer, A.J.¹ Tell, G.S.² Evans, G.W.³ Ettinger, W.H.J.⁴ Burkart, J.M.⁵

2
- 0033556545
- Reduction of acute renal allograft rejection by daclizumab. Daclizumab double therapy study group
- Nashan B, Light S, Hardie IR, Lin A, Johnson JR (1999) Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group. Transplantation 67: 110-115
- (1999) Transplantation , vol.67 , pp. 110-115
- Nashan, B.¹ Light, S.² Hardie, I.R.³ Lin, A.⁴ Johnson, J.R.⁵

3
- 0030716882
- Immunosuppressive therapy in high-risk transplant patients: Dose-dependent efficacy of mycophenolate mofetil in African-american renal allograft recipients
- U.S. Renal Transplant Mycophenolate Mofetil Study Group
- Neylan JF (1997) Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 64: 1277-1282
- (1997) Transplantation , vol.64 , pp. 1277-1282
- Neylan, J.F.¹

4
- 0032570530
- Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine
- FK506 Kidney Transplant Study Group
- Neylan JF (1998) Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. Transplantation 65: 515-523
- (1998) Transplantation , vol.65 , pp. 515-523
- Neylan, J.F.¹

5
- 0032570303
- Mycophenolate mofetil reduces the risk of acute rejection less in African-american than in Caucasian kidney recipients
- Schweitzer EJ, Yoon S, Fink J, Wiland A, Anderson L, Kuo PC, Lim JW, Johnson LB, Farney AC, Weir MR, Bartlett ST (1998) Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients. Transplantation 65: 242-248
- (1998) Transplantation , vol.65 , pp. 242-248
- Schweitzer, E.J.¹ Yoon, S.² Fink, J.³ Wiland, A.⁴ Anderson, L.⁵ Kuo, P.C.⁶ Lim, J.W.⁷ Johnson, L.B.⁸ Farney, A.C.⁹ Weir, M.R.¹⁰ Bartlett, S.T.¹¹

6
- 0031859825
- Late acute rejection is more prevalent among African-american renal allograft recipients and is frequently associated with allograft loss
- Vasquez EM, Benedetti E, Pollak R (1998) Late acute rejection is more prevalent among African-American renal allograft recipients and is frequently associated with allograft loss. Transplant Proc 30: 1173-1175
- (1998) Transplant Proc , vol.30 , pp. 1173-1175
- Vasquez, E.M.¹ Benedetti, E.² Pollak, R.³

7
- 0031014538
- A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation
- Vincenti F, Lantz M, Birnbaum J, Garovoy M, Mould D, Hakimi J, Nieforth K, Light S (1997) A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation. Transplantation 63: 33-38
- (1997) Transplantation , vol.63 , pp. 33-38
- Vincenti, F.¹ Lantz, M.² Birnbaum, J.³ Garovoy, M.⁴ Mould, D.⁵ Hakimi, J.⁶ Nieforth, K.⁷ Light, S.⁸

8
- 6844236357
- Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation
- Daclizumab Triple Therapy Study Group
- Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H, Gaston R, Backman L, Burdick J (1998) Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 338: 161-165
- (1998) N Engl J Med , vol.338 , pp. 161-165
- Vincenti, F.¹ Kirkman, R.² Light, S.³ Bumgardner, G.⁴ Pescovitz, M.⁵ Halloran, P.⁶ Neylan, J.⁷ Wilkinson, A.⁸ Ekberg, H.⁹ Gaston, R.¹⁰ Backman, L.¹¹ Burdick, J.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.